Acolad Spearheads Precision Communication at the 22nd Medicines for Europe Conference

Acolad is proud to announce its participation in the 22nd Medicines for Europe Regulatory Affairs and Pharmacovigilance Conference, set to take place in Brussels on September 27-28, 2023. With the unveiling of the European Commission's proposal for new pharmaceutical legislation, this conference promises to be a pivotal event for attendees seeking comprehensive insights into the proposed changes and their potential ramifications for the pharmaceutical industry's regulatory landscape.

Acolad recognizes the vital role of precision in translation and interpretation services, especially in the context of global clinical trials and regulatory compliance. Our team of experts stands ready to offer solutions that streamline communication and enhance collaboration among international teams, ensuring that regulatory operations remain effective and compliant. We invite you to visit us at the conference to discover how Acolad's services can contribute to your clinical research endeavors and navigate the evolving regulatory challenges within the industry.

Join us in Brussels to explore the potential of precise translation and interpretation services in regulatory affairs.

Meet the Team

Anne Ertlé-2

Anne Ertlé 
Senior Director, Strategic Accounts at Acolad Life Sciences

Véronique le Roux

Véronique le Roux 
Senior Business Development Manager  at Acolad Life Sciences

Content for you

Concept of biochemistry with dna molecule on blue background
New Clinical Trial Regulation: Finding the Support You Need

Read More
A doctor in white coat with a stethoscope on one shoulder holding a pill with green glowing graphs, lines, numbers, charts, between his fingers
Case Study
Cara Therapeutics Gets New Treatments FDA-Approved - With Acolad

Read More

Book a Meeting with an Expert